TY - JOUR T1 - An epigenetic proxy of chronic inflammation outperforms serum levels as a biomarker of brain ageing JF - medRxiv DO - 10.1101/2020.10.08.20205245 SP - 2020.10.08.20205245 AU - Eleanor L.S. Conole AU - Anna J. Stevenson AU - Claire Green AU - Sarah E. Harris AU - Susana Muñoz Maniega AU - María del. C Valdés-Hernández AU - Mathew A. Harris AU - Mark E. Bastin AU - Joanna M. Wardlaw AU - Ian J. Deary AU - Veronique E. Miron AU - Heather C. Whalley AU - Riccardo E. Marioni AU - Simon R. Cox Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/10/12/2020.10.08.20205245.abstract N2 - Low-level chronic inflammation increases with age and is associated with cognitive decline. DNA methylation (DNAm) levels may provide more stable reflections of cumulative inflammatory burden than traditional serum approaches. Using structural and diffusion MRI data from 521 individuals aged 73, we demonstrate that a DNAm proxy of C-Reactive Protein (CRP) shows significantly (on average 6.4-fold) stronger associations with brain structural outcomes than serum CRP. We additionally find that DNAm CRP has an inverse association with global and domain-specific (speed, visuospatial and memory) cognitive functioning, and that brain structure partially mediates this CRP-cognitive association (up to 29.4%), dependent on lifestyle and health factors. These data support the hypothesis that chronic systemic inflammation may contribute to neurodegenerative brain changes which underlie differences in cognitive ability in later life. DNA methylation-based predictors could be used as proxies for chronic inflammatory status.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe LBC1936 and this research are supported by Age UK (Disconnected Mind project) and by the UK Medical Research Council [MRC; G0701120, G1001245, MR/M013111/1, MR/K026992/1]. Methylation typing was supported by Centre for Cognitive Ageing and Cognitive Epidemiology (Pilot Fund award), Age UK, The Wellcome Trust Institutional Strategic Support Fund, The University of Edinburgh, and The University of Queensland. The Olink Proteomics assays were supported by a National Institutes of Health (NIH) research grant R01AG054628. This work was in part conducted in the Centre for Cognitive Ageing and Cognitive Epidemiology, which is supported by the Medical Research Council and Biotechnology and Biological Sciences Research Council (MR/K026992/1) and which supports IJD. E.L.S.C. and A.J.S. are supported by funding from the Wellcome Trust 4-year PhD in Translational Neuroscience [108890/Z/15/Z to E.L.S.C.; 203771/Z/16/Z to A.J.S]. M.E.B., I.J.D. and S.R.C. are also supported by a National Institutes of Health (NIH) research grant R01AG054628.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethical permission for the LBC1936 was obtained from the Multi-Centre Research Ethics Committee for Scotland (MREC/01/0/56) and the Lothian Research Ethics Committee (LREC/2003/2/29). Written informed consent was obtained from all participants.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data analysed in this study is not publicly available as it contains data that could compromise participant consent and confidentiality, but can be requested via a data access request to the Lothian Birth Cohorts research group. ER -